Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Medtronic
Dow
McKesson
Merck

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for LY03005


Email this page to a colleague

« Back to Dashboard

What is the drug development status for LY03005?

LY03005 is an investigational drug.

There have been 8 clinical trials for LY03005. The most recent clinical trial was a Phase 3 trial, which was initiated on December 5th 2018.

The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Luye Pharma Group Ltd., Shandong Luye Pharmaceutical Co., Ltd., and [disabled in preview].

There are four US patents protecting this investigational drug and fifty-one international patents.

Recent Clinical Trials for LY03005
TitleSponsorPhase
A Relative Bioavailability Food Effect Study of LY03005Luye Pharma Group Ltd.Phase 1
A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)Luye Pharma Group Ltd.Phase 3
A Study of LY03005 vs PristiqLuye Pharma Group Ltd.Phase 1

See all LY03005 clinical trials

Clinical Trial Summary for LY03005

Top disease conditions for LY03005
Top clinical trial sponsors for LY03005

See all LY03005 clinical trials

US Patents for LY03005

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
LY03005 ⤷  Sign up for a Free Trial Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof Shandong Luye Pharmaceutical Co., Ltd. (Yantai, Shandong, CN) Li; Youxin (Zhuzhou, Hunan, CN) ⤷  Sign up for a Free Trial
LY03005 ⤷  Sign up for a Free Trial Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof Shandong Luye Pharmaceutical Co. Ltd. (Yantai, CN) Li; Youxin (Zhuzhou, CN) ⤷  Sign up for a Free Trial
LY03005 ⤷  Sign up for a Free Trial Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methyl-benzoate hydrochloride, methods for preparing the same and use of the same Shangong Luye Pharmaceutical Co., Ltd. (Yantai, Shandong, CN) Li; Youxin (Langenfeld, DE) ⤷  Sign up for a Free Trial
LY03005 ⤷  Sign up for a Free Trial Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods of preparing the same and use of the same SHANDONG LUYE PHARMACEUTICAL CO., LTD. (Yantai, CN) Li; Youxin (Langenfield, DE) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for LY03005

Drugname Country Document Number Estimated Expiration Related US Patent
LY03005 Australia AU2006257558 2025-06-17 ⤷  Sign up for a Free Trial
LY03005 Canada CA2612413 2025-06-17 ⤷  Sign up for a Free Trial
LY03005 China CN1955159 2025-06-17 ⤷  Sign up for a Free Trial
LY03005 Denmark DK1897867 2025-06-17 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Medtronic
Dow
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.